TTCI Congratulates Prof. Nattiya Hirankarn on Receiving Two Prestigious Lecturer Awards in Health Sciences
October 15, 2026
BANGKOK, THAILAND – The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) proudly congratulates Prof. Nattiya Hirankarn, M.D., Ph.D., Director of TTCI and Associate Dean for Graduate Affairs, Faculty of Medicine, Chulalongkorn University, on receiving two prestigious academic honors recognizing her outstanding contributions to medical education, research, and leadership in health sciences.
Recognizing Excellence in Medical Education and Academic Leadership
Prof. Nattiya has been honored with two distinguished awards at both the university and national levels:
● Role Model Lecturer Award (Academic Year 2025/2568) in Health Sciences
Conferred by the Chulalongkorn University Senate, recognizing her exemplary dedication to teaching, academic leadership, and contributions to higher education.
● National Outstanding Lecturer Award (2026/2569) in Health Sciences
Conferred by the Council of University Faculty Senates of Thailand (CUFST / ปอมท.) at its 8th meeting on August 29, 2026, honoring her exceptional achievements and contributions to health sciences education at the national level.
Advancing Immunology Research and Medical Education in Thailand
These prestigious recognitions reflect Prof. Nattiya's longstanding commitment to academic excellence, innovative research, and the advancement of medical education in Thailand.
As Director of TTCI, she has played an important role in strengthening collaborative research networks, promoting scientific innovation, and advancing cancer immunotherapy research and development.
Her leadership continues to inspire researchers, healthcare professionals, and the next generation of medical scientists, contributing to the growth of Thailand's academic and healthcare communities.
Celebrating Outstanding Achievement and Inspiring Future Generations
The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) extends its warmest congratulations to Prof. Nattiya Hirankarn on these remarkable achievements.
These honors recognize her dedication, visionary leadership, and significant contributions to immunology research, medical education, and the advancement of healthcare and cancer immunotherapy in Thailand.
TTCI proudly celebrates this achievement and remains committed to advancing scientific excellence, academic collaboration, and innovation in cancer immunotherapy.
Official Website: www.ttci-th.org
Recognizing Excellence in Medical Education and Academic Leadership
Prof. Nattiya has been honored with two distinguished awards at both the university and national levels:
● Role Model Lecturer Award (Academic Year 2025/2568) in Health Sciences
Conferred by the Chulalongkorn University Senate, recognizing her exemplary dedication to teaching, academic leadership, and contributions to higher education.
● National Outstanding Lecturer Award (2026/2569) in Health Sciences
Conferred by the Council of University Faculty Senates of Thailand (CUFST / ปอมท.) at its 8th meeting on August 29, 2026, honoring her exceptional achievements and contributions to health sciences education at the national level.
Advancing Immunology Research and Medical Education in Thailand
These prestigious recognitions reflect Prof. Nattiya's longstanding commitment to academic excellence, innovative research, and the advancement of medical education in Thailand.
As Director of TTCI, she has played an important role in strengthening collaborative research networks, promoting scientific innovation, and advancing cancer immunotherapy research and development.
Her leadership continues to inspire researchers, healthcare professionals, and the next generation of medical scientists, contributing to the growth of Thailand's academic and healthcare communities.
Celebrating Outstanding Achievement and Inspiring Future Generations
The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) extends its warmest congratulations to Prof. Nattiya Hirankarn on these remarkable achievements.
These honors recognize her dedication, visionary leadership, and significant contributions to immunology research, medical education, and the advancement of healthcare and cancer immunotherapy in Thailand.
TTCI proudly celebrates this achievement and remains committed to advancing scientific excellence, academic collaboration, and innovation in cancer immunotherapy.
Official Website: www.ttci-th.org
